san antonio breast cancer symposium 2008: zoledronic acid may have anti-tumour properties
Published 14 years ago • 279 plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
3:56
san antonio breast cancer symposium 2008: poor prognosis on small, her2 positive tumours
-
7:23
san antonio breast cancer symposium 2008: new biomarker predicts anthracycline response.
-
1:35
why is it important to attend the san antonio breast cancer symposium?
-
21:52
dr. isaac chan | san antonio breast cancer symposium 2022
-
2:45
adjuvant zoledronic acid reduces breast cancer deaths
-
0:49
san antonio breast cancer symposium 2022 highlights
-
1:00
highlights from the san antonio breast cancer symposium 2022
-
1:01:02
report back from san antonio breast cancer symposium on metastatic breast cancer
-
22:23
dr. mikala egeblad | san antonio breast cancer symposium
-
3:27
sabcs: more evidence that bisphosphonates prevent breast cancer
-
58:11
latest research on metastatic breast cancer from san antonio breast cancer symposium
-
0:56
the san antonio breast cancer symposium (sabcs) 2022
-
2:57
key data from the san antonio breast cancer symposium (sabcs) 2022
-
1:02:06
report back from san antonio breast cancer symposium (sabcs 2022)
-
1:07
recent breast cancer updates from sabcs 2021
-
21:39
new research in metastatic breast cancer | sabcs 2019
-
17:19
dr. carmen bergom | san antonio breast cancer symposium 2022 | educational session
-
2:56
san antonio breast cancer symposium
-
27:09
dr. susan dent | san antonio breast cancer symposium 2022 | educational session